Literature DB >> 19010255

NMD: multitasking between mRNA surveillance and modulation of gene expression.

Gabriele Neu-Yilik1, Andreas E Kulozik1.   

Abstract

Gene expression is a highly specific and regulated multilayer process with a plethora of interconnections as well as safeguard and feedback mechanisms. Messenger RNA, long neglected as a mere subcarrier of genetic information, is more recently recognized as a linchpin of regulation and control of gene expression. Moreover, the awareness of not only proteins but also mRNA as a modulator of genetic disorders has vastly increased in recent years. Nonsense-mediated mRNA decay (NMD) is a posttranscriptional surveillance mechanism that uses an intricate network of nuclear and cytoplasmic processes to eliminate mRNAs, containing premature termination codons. It thus helps limit the synthesis of potentially harmful truncated proteins. However, recent results suggest functions of NMD that go far beyond this role and affect the expression of wild-type genes and the modulation of whole pathways. In both respects--the elimination of faulty transcripts and the regulation of error-free mRNAs--NMD has many medical implications. Therefore, it has earned increasing interest from researchers of all fields of the life sciences. In the following text, we (1) present current knowledge about the NMD mechanism and its targets, (2) define its relevance in the regulation of important biochemical pathways, (3) explore its medical significance and the prospects of therapeutic interventions, and (4) discuss additional functions of NMD effectors, some of which may be networked to NMD. The main focus of this chapter lies on mammalian NMD and resorts to the features and factors of NMD in other organisms if these help to complete or illuminate the picture.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19010255     DOI: 10.1016/S0065-2660(08)00604-4

Source DB:  PubMed          Journal:  Adv Genet        ISSN: 0065-2660            Impact factor:   1.944


  32 in total

Review 1.  The exozyme model: a continuum of functionally distinct complexes.

Authors:  Daniel L Kiss; Erik D Andrulis
Journal:  RNA       Date:  2010-11-10       Impact factor: 4.942

2.  Plant upstream ORFs can trigger nonsense-mediated mRNA decay in a size-dependent manner.

Authors:  Tünde Nyikó; Boglárka Sonkoly; Zsuzsanna Mérai; Anna Hangyáné Benkovics; Dániel Silhavy
Journal:  Plant Mol Biol       Date:  2009-08-04       Impact factor: 4.076

Review 3.  Structural aspects of translation termination on the ribosome.

Authors:  Andrei A Korostelev
Journal:  RNA       Date:  2011-06-23       Impact factor: 4.942

4.  Mechanism of escape from nonsense-mediated mRNA decay of human beta-globin transcripts with nonsense mutations in the first exon.

Authors:  Gabriele Neu-Yilik; Beate Amthor; Niels H Gehring; Sharif Bahri; Helena Paidassi; Matthias W Hentze; Andreas E Kulozik
Journal:  RNA       Date:  2011-03-09       Impact factor: 4.942

5.  Identification of hundreds of novel UPF1 target transcripts by direct determination of whole transcriptome stability.

Authors:  Hidenori Tani; Naoto Imamachi; Kazi Abdus Salam; Rena Mizutani; Kenichi Ijiri; Takuma Irie; Tetsushi Yada; Yutaka Suzuki; Nobuyoshi Akimitsu
Journal:  RNA Biol       Date:  2012-10-12       Impact factor: 4.652

6.  microRNA/Argonaute 2 regulates nonsense-mediated messenger RNA decay.

Authors:  Junho Choe; Hana Cho; Hyung Chul Lee; Yoon Ki Kim
Journal:  EMBO Rep       Date:  2010-04-16       Impact factor: 8.807

Review 7.  Gene expression networks: competing mRNA decay pathways in mammalian cells.

Authors:  Lynne E Maquat; Chenguang Gong
Journal:  Biochem Soc Trans       Date:  2009-12       Impact factor: 5.407

Review 8.  Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action.

Authors:  Seth A Brooks; Perry J Blackshear
Journal:  Biochim Biophys Acta       Date:  2013-02-18

9.  Reinforcement of a minor alternative splicing event in MYO7A due to a missense mutation results in a mild form of retinopathy and deafness.

Authors:  Imen Ben Rebeh; Madeleine Morinière; Leila Ayadi; Zeineb Benzina; Ilhem Charfedine; Jamel Feki; Hammadi Ayadi; Abdelmonem Ghorbel; Faouzi Baklouti; Saber Masmoudi
Journal:  Mol Vis       Date:  2010-09-30       Impact factor: 2.367

10.  Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension.

Authors:  Eric D Austin; John A Phillips; Joy D Cogan; Rizwan Hamid; Chang Yu; Krista C Stanton; Charles A Phillips; Lisa A Wheeler; Ivan M Robbins; John H Newman; James E Loyd
Journal:  Respir Res       Date:  2009-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.